Drug intelligence / Profile preview

Elental + aminosalicylates

Development stage
Unknown
Lead developer
Ajinomoto
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Elental + aminosalicylates is a combination therapy consisting of Elental, an elemental diet formula, and aminosalicylate drugs (5-aminosalicylates or 5-ASA). Elental is a nutritionally complete elemental diet used primarily in Japan for patients with inflammatory bowel disease (IBD) and other gastrointestinal disorders; it provides nutrients in easily absorbable forms to reduce digestive workload. Aminosalicylates are anti-inflammatory agents that inhibit the production of cyclooxygenase, prostaglandins, thromboxane synthetase, platelet activating factor synthetase, and interleukin-1 by macrophages. This reduces acute inflammation in IBD such as ulcerative colitis and Crohn’s disease. The combination may be used to induce or maintain remission in IBD by providing both nutritional support (via Elental) and direct anti-inflammatory action (via aminosalicylates).

02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)Platelet Activating Factor SynthetaseTBXAS1 (Thromboxane A2 synthase)

Beyond the preview

Go deeper on Elental + aminosalicylates.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elental + aminosalicylates.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call